Literature DB >> 32057979

Prevalence of β-lactamase and antibiotic-resistant Pseudomonas aeruginosa in the Arab region.

Mahfouz Nasser1, Samarpita Gayen1, Arun S Kharat2.   

Abstract

BACKGROUND: Several studies in the Arab region have recognised the rate of nosocomial infections caused by Pseudomonas aeruginosa (P. aeruginosa), which produce β-lactamase, and identified their emergence and prevalence in the region. This article reviewed molecular studies on these β-lactamase-producing P. aeruginosa during 2010-2018 in several countries of the Arab region in order to analyse the trend of rising prevalence of disease causing drug-resistant P. aeruginosa in the Arab region.
METHODS: Data from selected clinical studies during 2010-2018 on β-lactamase-producing P. aeruginosa in the Arab region were obtained from reliable scientific databases for analysis and evaluation.
RESULTS: Significant changes were found in resistance of P. aeruginosa towards certain antibiotics of the β-lactam class. There was an increasing trend in the occurrence of resistance genes in β-lactamase-producing P. aeruginosa.
CONCLUSION: This review showed that there is an increasing prevalence of β-lactamase-producing P. aeruginosa in some countries in the Arab region. This is a major cause of concern as this implies that more and more instances of multidrug resistance are emerging in this area. This leads to an overall negative impact on health concerns and amounts to increasing difficulty in combating disease. It is recommended that awareness about antibiotic use and abuse be made a priority and measures to curb unchecked use of prescription antibiotics be put into place. Effective screening methods to detect cases of resistance at their onset may be developed.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Arab region; Molecular; Pseudomonas aeruginosa; β-lactamase

Mesh:

Substances:

Year:  2020        PMID: 32057979     DOI: 10.1016/j.jgar.2020.01.011

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  5 in total

1.  Pharmacokinetics of meropenem in critically ill patients in Saudi Arabia.

Authors:  Abdullah Alsultan; Shereen A Dasuqi; Fadi Aljamaan; Rasha A Omran; Saeed Ali Syed; Turki AlJaloud; Abdullah AlAhmadi; Saeed Alqahtani; Mohammed A Hamad
Journal:  Saudi Pharm J       Date:  2021-10-08       Impact factor: 4.330

Review 2.  Emerging Status of Multidrug-Resistant Bacteria and Fungi in the Arabian Peninsula.

Authors:  J Francis Borgio; Alia Saeed Rasdan; Bayan Sonbol; Galyah Alhamid; Noor B Almandil; Sayed AbdulAzeez
Journal:  Biology (Basel)       Date:  2021-11-06

3.  Molecular epidemiology and collaboration of siderophore-based iron acquisition with surface adhesion in hypervirulent Pseudomonas aeruginosa isolates from wound infections.

Authors:  Hamed Tahmasebi; Sanaz Dehbashi; Mona Nasaj; Mohammad Reza Arabestani
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

4.  High prevalence of blaVEB , blaGES and blaPER genes in beta-lactam resistant clinical isolates of Pseudomonas aeruginosa.

Authors:  Saboura Haghighi; Hamid Reza Goli
Journal:  AIMS Microbiol       Date:  2022-04-25

Review 5.  β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects.

Authors:  Karl A Glen; Iain L Lamont
Journal:  Pathogens       Date:  2021-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.